RINALDI, FRANCESCO
RINALDI, FRANCESCO
ARAG - AREA FINANZA E CONTABILITÀ
Collaboratori
An integrative structural study of RAD52, an emerging target in anticancer drug discovery
2025 Rinaldi, F.; Balboni, B.; Girotto, S.; Cavalli, A.
Dissecting the RAD51-BRC4 Interaction Landscape through Integrative Molecular Simulations and Experimental Biophysics
2025 Bresciani, V.; Rinaldi, F.; Franco, P.; Girotto, S.; Cavalli, A.; Langer, J. D.; Masetti, M.; Bernetti, M.
Elucidating RAD52 architecture through an integrated structural biology approach
2025 Rinaldi, F.; Balboni, B.; Marotta, R.; Girotto, S.; Cavalli, A.
Elucidating the BRCA2-RAD51 interaction through an integrated biophysical and structural biology approach
2025 Rinaldi, F.; Bresciani, V.; Franco, P.; Bernetti, M.; Langer, J.; Cavalli, A.; Girotto, S.
Probing the BRC repeats RAD51 interaction by integrating computational and experimental biophysics
2025 Rinaldi, F.; Bresciani, V.; Franco, P.; Veronesi, M.; Bernetti, M.; Masetti, M.; Langer, J.; Cavalli, A.; Girotto, S.
The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study
2025 Rinaldi, F.; Bernetti, M.; Bresciani, V.; Veronesi, M.; Masetti, M.; Girotto, S.; Cavalli, A.
The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study
2025 Rinaldi, F.; Bernetti, M.; Bresciani, V.; Veronesi, M.; Masetti, M.; Girotto, S.; Cavalli, A.
Understanding how structure shapes the architecture of homologous recombination
2025 Rinaldi, F.; Girotto, S.
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery
2024 Bagnolini G., Poppi L., Previtali V., Ferrandi G., Rinaldi F., Girotto S., Hirsch A.K.H., Roberti M., Cavalli A.
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution
2024 Balboni, Beatrice; Marotta, Roberto; Rinaldi, Francesco; Milordini, Giulia; Varignani, Giulia; Girotto, Stefania; Cavalli, Andrea
Combining computational and experimental methods to characterize the RAD51-BRC repeats interaction
2024 Bresciani V., Rinaldi F., Bernetti M., Masetti M.
Elucidating the RAD51-BRC repeats interaction by integrating computational and experimental approaches
2024 Bresciani V., Rinaldi F., Bernetti M., Masetti M.
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
2024 Previtali, Viola; Bagnolini, Greta; Ciamarone, Andrea; Ferrandi, Giovanni; Rinaldi, Francesco; Myers, Samuel Harry; Roberti, Marinella; Cavalli, Andrea
Structure-based approaches in synthetic lethality strategies
2024 Rinaldi, F.; Girotto, S.
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer
2023 Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
2023 Myers, S. H.; Poppi, L.; Rinaldi, F.; Veronesi, M.; Ciamarone, A.; Previtali, V.; Bagnolini, G.; Schipani, F.; Ortega Martínez, J. A.; Girotto, S.; Di Stefano, G.; Farabegoli, F.; Walsh, N.; De Franco, F.; Roberti, M.; Cavalli, A.
Dissecting the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics
2023 Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
Elucidating the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics
2023 Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
Elucidating the BRCA2-RAD51 interaction through an integrated structural biophysics approach
2023 Rinaldi Francesco, Girotto Stefania, Cavalli Andrea
Integration of computational and experimental biophysics reveals novel insights on the BRCA2 - RAD51 interaction
2023 Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| An integrative structural study of RAD52, an emerging target in anticancer drug discovery | Rinaldi, F.; Balboni, B.; Girotto, S.; Cavalli, A. | 2025-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Dissecting the RAD51-BRC4 Interaction Landscape through Integrative Molecular Simulations and Experimental Biophysics | Bresciani, V.; Rinaldi, F.; Franco, P.; Girotto, S.; Cavalli, A.; Langer, J. D.; Masetti, M.; Ber...netti, M. | 2025-01-01 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | - | 1.01 Articolo in rivista | - |
| Elucidating RAD52 architecture through an integrated structural biology approach | Rinaldi, F.; Balboni, B.; Marotta, R.; Girotto, S.; Cavalli, A. | 2025-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Elucidating the BRCA2-RAD51 interaction through an integrated biophysical and structural biology approach | Rinaldi, F.; Bresciani, V.; Franco, P.; Bernetti, M.; Langer, J.; Cavalli, A.; Girotto, S. | 2025-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Probing the BRC repeats RAD51 interaction by integrating computational and experimental biophysics | Rinaldi, F.; Bresciani, V.; Franco, P.; Veronesi, M.; Bernetti, M.; Masetti, M.; Langer, J.; Cava...lli, A.; Girotto, S. | 2025-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study | Rinaldi, F.; Bernetti, M.; Bresciani, V.; Veronesi, M.; Masetti, M.; Girotto, S.; Cavalli, A. | 2025-01-01 | - | - | 4.03 Poster | - |
| The mechanistic understanding of the BRCA2-RAD51 interaction: an integrated structural biophysics study | Rinaldi, F.; Bernetti, M.; Bresciani, V.; Veronesi, M.; Masetti, M.; Girotto, S.; Cavalli, A. | 2025-01-01 | - | - | 4.03 Poster | - |
| Understanding how structure shapes the architecture of homologous recombination | Rinaldi, F.; Girotto, S. | 2025-01-01 | CURRENT OPINION IN STRUCTURAL BIOLOGY | - | 1.01 Articolo in rivista | - |
| A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery | Bagnolini G., Poppi L., Previtali V., Ferrandi G., Rinaldi F., Girotto S., Hirsch A.K.H., Roberti... M., Cavalli A. | 2024-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| An integrative structural study of the human full-length RAD52 at 2.2 Å resolution | Balboni, Beatrice; Marotta, Roberto; Rinaldi, Francesco; Milordini, Giulia; Varignani, Giulia; Gi...rotto, Stefania; Cavalli, Andrea | 2024-01-01 | COMMUNICATIONS BIOLOGY | - | 1.01 Articolo in rivista | s42003-024-06644-1.pdf |
| Combining computational and experimental methods to characterize the RAD51-BRC repeats interaction | Bresciani V., Rinaldi F., Bernetti M., Masetti M. | 2024-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Elucidating the RAD51-BRC repeats interaction by integrating computational and experimental approaches | Bresciani V., Rinaldi F., Bernetti M., Masetti M. | 2024-01-01 | - | - | 4.03 Poster | - |
| New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives | Previtali, Viola; Bagnolini, Greta; Ciamarone, Andrea; Ferrandi, Giovanni; Rinaldi, Francesco; My...ers, Samuel Harry; Roberti, Marinella; Cavalli, Andrea | 2024-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | New Horizons of Synthetic Lethality in Cancer_ Current Development and Future Perspectives.pdf |
| Structure-based approaches in synthetic lethality strategies | Rinaldi, F.; Girotto, S. | 2024-01-01 | CURRENT OPINION IN STRUCTURAL BIOLOGY | - | 1.01 Articolo in rivista | - |
| A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer | Laura Poppi, Samuel H Myers, Viola Previtali, Francesco Rinaldi, Fulvia Farabegoli, Giuseppina Di... Stefano, Naomi Walsh, Marinella Roberti, Andrea Cavalli | 2023-01-01 | - | FEBS PRESS | 4.03 Poster | - |
| An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer | Myers, S. H.; Poppi, L.; Rinaldi, F.; Veronesi, M.; Ciamarone, A.; Previtali, V.; Bagnolini, G.; ...Schipani, F.; Ortega Martínez, J. A.; Girotto, S.; Di Stefano, G.; Farabegoli, F.; Walsh, N.; De Franco, F.; Roberti, M.; Cavalli, A. | 2023-01-01 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | 1-s2.0-S0223523423010814-mmc1.docx; 1-s2.0-S0223523423010814-main.pdf |
| Dissecting the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics | Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A. | 2023-01-01 | - | - | 4.03 Poster | - |
| Elucidating the BRCA2 - RAD51 interaction by integrating computational and experimental biophysics | Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A. | 2023-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Elucidating the BRCA2-RAD51 interaction through an integrated structural biophysics approach | Rinaldi Francesco, Girotto Stefania, Cavalli Andrea | 2023-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Integration of computational and experimental biophysics reveals novel insights on the BRCA2 - RAD51 interaction | Rinaldi F., Bernetti M., Bresciani V., Girotto S., Cavalli A. | 2023-01-01 | - | - | 4.03 Poster | - |